Literature DB >> 31978803

6-Gingerol ameliorates sepsis-induced liver injury through the Nrf2 pathway.

Mu-Keng Hong1, Lan-Lan Hu2, Ya-Xin Zhang1, Yu-Ling Xu1, Xiao-Yu Liu1, Pei-Kun He1, Yu-Hua Jia3.   

Abstract

Sepsis-induced liver injury is very common in intensive care units. Here, we investigated the effects of 6-gingerol on sepsis-induced liver injury and the role of the Nrf2 pathway in this process. 6-Gingerol is the principal ingredient of ginger that exerts anti-inflammatory and antioxidant effects. Using cecal ligation and puncture (CLP) to induce polymicrobial sepsis and related liver injury, we found that mice pre-treated with 6-Gingerol showed less incidences of severe liver inflammation and death than untreated CLP groups. 6-Gingerol administration also inhibited the expression of pyroptosis-related proteins, including NOD-like receptor protein 3 (NLRP3), IL-1β, and caspase-1. Consistent with these findings, 6-gingerol reduced the effects of pyroptosis induced by lipopolysaccharide (LPS) and adenosine 5'-triphosphate (ATP) in RAW 264.7 cells, as evidenced by IL-1β and caspase-1 protein levels in the supernatant and propidium iodide (PI) staining. 6-Gingerol was shown to activate the Nrf2 pathway in vivo and in vitro. Notably, Nrf2 siRNA transfection nullified the inhibitory effects of 6-gingerol on pyroptosis in vitro. In summary, these findings suggested that 6-gingerol alleviated sepsis-induced liver injury by inhibiting pyroptosis through the Nrf2 pathway.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6-Gingerol; Liver injury; Nuclear factor erythroid-2 related factor 2; Pyroptosis; Sepsis

Year:  2020        PMID: 31978803     DOI: 10.1016/j.intimp.2020.106196

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  8 in total

1.  Divya-Herbal-Peya Decoction Harmonizes the Inflammatory Response in Lipopolysaccharide-Induced Zebrafish Model.

Authors:  Acharya Balkrishna; Savita Lochab; Monali Joshi; Jyotish Srivastava; Anurag Varshney
Journal:  J Exp Pharmacol       Date:  2021-12-02

2.  Characteristics of Computed Tomography Images for Patients with Acute Liver Injury Caused by Sepsis under Deep Learning Algorithm.

Authors:  Huijun Wang; Qianqian Bao; Donghang Cao; Shujing Dong; Lili Wu
Journal:  Contrast Media Mol Imaging       Date:  2022-03-20       Impact factor: 3.161

3.  6-Gingerol suppresses cell viability, migration and invasion via inhibiting EMT, and inducing autophagy and ferroptosis in LPS-stimulated and LPS-unstimulated prostate cancer cells.

Authors:  Chi-Ming Liu; Lijie An; Zhengping Wu; Ai-Jun Ouyang; Mengqiao Su; Zichen Shao; Yi Lin; Xiaoyu Liu; Yinjie Jiang
Journal:  Oncol Lett       Date:  2022-04-26       Impact factor: 2.967

4.  Synergistic Anti-Inflammatory Activity of Ginger and Turmeric Extracts in Inhibiting Lipopolysaccharide and Interferon-γ-Induced Proinflammatory Mediators.

Authors:  Xian Zhou; Sualiha Afzal; Hans Wohlmuth; Gerald Münch; David Leach; Mitchell Low; Chun Guang Li
Journal:  Molecules       Date:  2022-06-16       Impact factor: 4.927

Review 5.  Bioactive Compounds from the Zingiberaceae Family with Known Antioxidant Activities for Possible Therapeutic Uses.

Authors:  Raphael N Alolga; Feizuo Wang; Xinyao Zhang; Jia Li; Lam-Son Phan Tran; Xiaojian Yin
Journal:  Antioxidants (Basel)       Date:  2022-06-28

6.  circ-Katnal1 Enhances Inflammatory Pyroptosis in Sepsis-Induced Liver Injury through the miR-31-5p/GSDMD Axis.

Authors:  Kai Kang; Nana Li; Yang Gao; Changsong Wang; Pengfei Chen; Xianglin Meng; Wei Yang; Mingyan Zhao; Kaijiang Yu
Journal:  Mediators Inflamm       Date:  2022-08-08       Impact factor: 4.529

7.  6-Gingerol attenuates subarachnoid hemorrhage-induced early brain injury via GBP2/PI3K/AKT pathway in the rat model.

Authors:  Hui Tang; Chuan Shao; Xiaoya Wang; Yi Cao; Zhou Li; Xiaoquan Luo; Xiang Yang; Yuekang Zhang
Journal:  Front Pharmacol       Date:  2022-08-25       Impact factor: 5.988

Review 8.  A Review of Malaysian Herbal Plants and Their Active Constituents with Potential Therapeutic Applications in Sepsis.

Authors:  Kong Yen Liew; Md Faizul Hafiz; Yi Joong Chong; Hanis Hazeera Harith; Daud Ahmad Israf; Chau Ling Tham
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-28       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.